Source: Graefe's Archive for Clinical and Experimental Ophthalmology. Unidade: FMRP
Subjects: ACUIDADE VISUAL, DIABETES MELLITUS, OFTALMOPATIAS
ABNT
RODRIGUES JÚNIOR, Murilo Wendeborn et al. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, v. 258, n. 3, p. 479-490, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00417-019-04564-z. Acesso em: 24 ago. 2024.APA
Rodrigues Júnior, M. W., Cardillo, J. A., Messias, A. M. V., Siqueira, R. C., Scott, I. U., & Jorge, R. (2020). Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, 258( 3), 479-490. doi:10.1007/s00417-019-04564-zNLM
Rodrigues Júnior MW, Cardillo JA, Messias AMV, Siqueira RC, Scott IU, Jorge R. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020 ; 258( 3): 479-490.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1007/s00417-019-04564-zVancouver
Rodrigues Júnior MW, Cardillo JA, Messias AMV, Siqueira RC, Scott IU, Jorge R. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020 ; 258( 3): 479-490.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1007/s00417-019-04564-z